RX-1 Rhythm Express Remote Cardiac Monitoring System is an AI-enabled medical device from VivaQuant Inc., listed by FDA (510(k), K183704) with a decision date of 2019-02-16. Review panel: Cardiovascular.
| FDA submission number | K183704 |
|---|---|
| Pathway | 510(k) |
| Company | VivaQuant Inc. |
| Review panel (specialty) | Cardiovascular |
| FDA decision date | 2019-02-16 |
| Decision | Substantially Equivalent |
| Product code | DXH |
| Classification | Transmitters And Receivers, Electrocardiograph, Telephone |
| Device class | 2 |
| Regulation number | 870.2920 |
| Review time (calendar days) | 47 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
All Cardiovascular AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.